ORIFARM GROUP A/S

ORIFARM GROUP A/S (CVR number: 27347282) is a company from ODENSE. The company reported a net sales of 3.7 mEUR in 2023, demonstrating a growth of 6.6 % compared to the previous year. The operating profit percentage was poor at -541.3 % (EBIT: -19.8 mEUR), while net earnings were 22.4 mEUR. The profitability of the company measured by Return on Assets (ROA) was 10.4 %, which can be considered good and Return on Equity (ROE) was 11.4 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 18.8 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. ORIFARM GROUP A/S's liquidity measured by quick ratio was 1.4 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.